Mandarin Capital Triples Investment In Italian Pharma Co.
Chinese private equity firm Mandarin Capital Partners has reportedly tripled its investment in a Milan-based pharmaceutical company after selling part of its majority stake to Italian firm Clessidra SGR SPA....To view the full article, register now.
Already a subscriber? Click here to view full article